Skip to main content
Propanc Biopharma, Inc. logo

Propanc Biopharma, Inc. — Investor Relations & Filings

Ticker · PPCB ISIN · US74346N4043 LEI · 549300Q3HY827FNV8Y56 US Professional, scientific and technical activities
Open in API
Filings indexed 412 across all filing types
Latest filing 2012-02-21 Interim / Quarterly Rep…
Country US United States of America
Listing US PPCB

About Propanc Biopharma, Inc.

https://www.propanc.com/

Propanc Biopharma, Inc. is a clinical-stage company developing cancer treatments focused on preventing tumor recurrence and metastasis. Its lead candidate, PRP, is a pancreatic proenzyme formulation designed to target and eradicate cancer stem cells. The therapeutic approach aims to suppress tumor progression by controlling cancer cell migration, inhibiting the formation of tumor blood vessels, and inducing cell death. The company's primary focus is on developing long-term therapies for patients with solid tumors, such as pancreatic cancer.

Recent filings

Filing Released Lang Actions
QUARTERLY REPORT
Interim / Quarterly Report Q2 2012
2012-02-21 English
NOTIFICATION OF LATE FILING
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically states that the company could not file its Form 10-Q (quarterly report) on time and is requesting an extension. The document contains no actual financial data or substantive financial analysis but is merely a notification about the delay in filing the quarterly report. According to the rules, such a notification is classified as a Regulatory Filing (RNS) because it is an official regulatory announcement related to filing compliance, not the report itself.
2012-02-14 English
PROSPECTUS
Capital/Financing Update Classification · 95% confidence The document is a detailed prospectus filed pursuant to Rule 424(b)(3) for the offering of common stock by Propanc Health Group Corporation. It includes extensive information about the offering, use of proceeds, risk factors, management discussion and analysis, business description, executive compensation, principal shareholders, and financial statements. The document is not a report of financial results, audit, or earnings release, but rather a capital raising document describing the terms and conditions of a stock offering. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and financing activities. The document length is substantial (15,000 characters), and it is not merely an announcement or a brief summary, so it is not an RPA or RNS. Therefore, the correct classification is CAP with high confidence.
2011-12-16 English
Regulatory Filings 2011
Regulatory Filings
2011-12-16 English
Regulatory Filings 2011
Regulatory Filings Classification · 95% confidence The document is a letter from Propanc Health Group Corporation to the SEC Division of Corporation Finance requesting acceleration of effectiveness of a Registration Statement on Form S-1. It references the Registration Statement and Rule 461 under the Securities Act of 1933. The document is short (2022 characters) and is a correspondence related to a regulatory filing, not the filing itself. It does not contain financial data or report content but is a procedural communication. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and correspondence that do not fit other categories.
2011-12-13 English
Regulatory Filings 2011
Regulatory Filings Classification · 95% confidence The document is a correspondence letter to the SEC regarding Amendment No. 5 to a Registration Statement on Form S-1. It mentions filing an amendment to the Registration Statement and includes financial statements for the quarter ended September 30, 2011. The document is short (1768 characters) and primarily serves as a cover letter or correspondence about the filing rather than the filing itself. It references the Form S-1 amendment and attached financial statements but does not contain the full registration statement or detailed financial data itself. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for correspondence and miscellaneous filings that do not fit other categories.
2011-12-08 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.